Liver fatty acid binding protein 1 (FABP1) plays a critical role in bile acid and cholesterol metabolism in mice

被引:0
|
作者
Seneshaw, M
Klass, D
Preiss, E
Adler, G
Davidson, NO
Fuchs, M
机构
[1] Univ Ulm, Dept Med 1, Ulm, Germany
[2] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
下载
收藏
页码:24 / 24
页数:1
相关论文
共 50 条
  • [1] Compensatory hepatic up-regulation of bile acid synthesis in liver fatty acid binding protein (FABP1) knockout mice provides novel insights into the physiological role of FABP1
    Seneshaw, Mulugeta
    Klass, Dietmar
    Elizabeth, Newberry
    Preiss, Elke
    Seedorf, Udo
    Adler, Guido
    Davidson, Nicholas O.
    Fuchs, Michael
    GASTROENTEROLOGY, 2006, 130 (04) : A376 - A376
  • [2] Hepatobiliary lipid metabolism is impaired in liver fatty acid binding protein 1 (FABP1) deficient mice.
    Seneshaw, M
    Klass, D
    Adler, G
    Davidson, N
    Fuchs, M
    HEPATOLOGY, 2004, 40 (04) : 492A - 492A
  • [3] Drugs Form Ternary Complexes with Human Liver Fatty Acid Binding Protein 1 (FABP1) and FABP1 Binding Alters Drug Metabolism S
    Yabut, King Clyde B.
    Martynova, Alice
    Nath, Abhinav
    Zercher, Benjamin P.
    Bush, Matthew F.
    Isoherranen, Nina
    MOLECULAR PHARMACOLOGY, 2024, 105 (06) : 395 - 410
  • [4] Liver fatty acid binding protein 1 (FABP1) regulates the alternative bile acid synthetic pathway and promotes cholehepatic shunting of bile acids
    Seneshaw, Mulugeta
    Newberry, Elizabeth F.
    Preiss, Elke
    Adler, Guido
    Davidson, Nicholas O.
    Fuchs, Michael
    GASTROENTEROLOGY, 2007, 132 (04) : A2 - A2
  • [5] Structural and Functional Interaction of Δ9-Tetrahydrocannabinol with Liver Fatty Acid Binding Protein (FABP1)
    Huang, Huan
    McIntosh, Avery L.
    Martin, Gregory G.
    Dangott, Lawrence J.
    Kier, Ann B.
    Schroeder, Friedhelm
    BIOCHEMISTRY, 2018, 57 (41) : 6027 - 6042
  • [6] Fatty Acid Binding Protein-1 (FABP1) and the Human FABP1 T94A Variant: Roles in the Endocannabinoid System and Dyslipidemias
    Schroeder, Friedhelm
    McIntosh, Avery L.
    Martin, Gregory G.
    Huang, Huan
    Landrock, Danilo
    Chung, Sarah
    Landrock, Kerstin K.
    Dangott, Lawrence J.
    Li, Shengrong
    Kaczocha, Martin
    Murphy, Eric J.
    Atshaves, Barbara P.
    Kier, Ann B.
    LIPIDS, 2016, 51 (06) : 655 - 676
  • [7] Liver fatty-acid-binding protein (L-FABP) gene ablation alters liver bile acid metabolism in male mice
    Martin, GG
    Atshaves, BP
    McIntosh, AL
    Mackie, JT
    Kier, AB
    Schroeder, F
    BIOCHEMICAL JOURNAL, 2005, 391 : 549 - 560
  • [8] The human liver fatty acid binding protein (FABP1) gene is activated by FOXA1 and PPARα; and repressed by C/EBPα: Implications in FABP1 down-regulation in nonalcoholic fatty liver disease
    Guzman, Carla
    Benet, Marta
    Pisonero-Vaquero, Sandra
    Moya, Marta
    Victoria Garcia-Mediavilla, M.
    Luz Martinez-Chantar, M.
    Gonzalez-Gallego, Javier
    Vicente Castell, Jose
    Sanchez-Campos, Sonia
    Jover, Ramiro
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2013, 1831 (04): : 803 - 818
  • [9] Characterization of Drug Binding to Liver Fatty Acid Binding Protein (FABP1) and Its Effect on Diclofenac Metabolism by CYP2C9
    Yabut, King B.
    Zercher, Ben
    Bush, Matthew F.
    Isoherranen, Nina
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2023, 385
  • [10] Circulating fatty acid-binding protein 1 (FABP1) and nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus
    Lu, Yung-Chuan
    Chan, Chi-Chang
    Wang, Chao Ping
    Hung, Wei-Chin
    Tsai, I-Ting
    Tang, Wei-Hua
    Wu, Cheng-Ching
    Wei, Ching-Ting
    Chung, Fu-Mei
    Lee, Yau-Jiunn
    Hsu, Chia-Chang
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2020, 17 (02): : 182 - 190